pamidronate has been researched along with Carcinoma, Adenosquamous in 1 studies
Carcinoma, Adenosquamous: A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate was well tolerated and only grade 1 or 2 toxicities were registered." | 1.35 | Routine use of pamidronate in NSCLC patients with bone metastasis: results from a retrospective analysis. ( Mitterer, M; Seeber, A; Spizzo, G, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spizzo, G | 1 |
| Seeber, A | 1 |
| Mitterer, M | 1 |
1 other study available for pamidronate and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
Routine use of pamidronate in NSCLC patients with bone metastasis: results from a retrospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Ad | 2009 |